Dr Spoorthi G

Dr Spoorthi G

Consultant Medical and Hemato Oncologist

Medical & Hemato Oncologist in Bangalore – Dr. Spoorthi G

Dr. Spoorthi G is a Consultant in Medical Oncology at Cancer Therapy India, specializing in advanced cancer treatment, chemotherapy, targeted therapy, and personalized oncology care. With expertise in managing complex cancer cases, she focuses on compassionate, evidence-based treatment and improved patient outcomes.

Qualifications
  • DrNB in Medical Oncology – HCG Hospitals, Bangalore | 2023 – 2026
  • MD Internal Medicine – RGUHS University, Navodaya Medical College and Research Centre | 2016-2019
  • MBBS – RGUHS University, Belagavi institute of Medical Sciences (BIMS) | 2009-2015
Work Experience
  • Rotational postings in Jayadeva Institute of Cardiology, NIMHANS, Institute of Nephrourology (INU), KIDWAI Oncology center for 8 months | 2019
  • Senior Residency in Internal Medicine, VIMS, Bellary | 2020-2021
  • Junior Consultant at NH, JSW, Bellary | 2022
Scientific work and Research
  • Thesis MD Medicine: To study clinical profile of Malaria with reference to Hepatopathy
  • Paper and Poster presentation at the National Conference APICON held in Bengaluru
  • Oral paper presentation in State medical Conference of Medical Association held in Raichur
  • Contribution as a co-author with Dr Govind Babu on Targeted therapy in lung cancer in the API Textbook for physicians 2024
  •  Case report publication on “Triple Chaos: A case of concurrent RCC with Urothelial cancer and Non Hodgkins Lymphoma” in the Indian Journal of Cancer
  • Represented HCG Hospital at debate held in KIDWAI, Bangalore in June 2024 on the topic “Double Immunotherapy vs Immunotherapy + TKI in mRCC”
  • Presentation on TALAPRO-2 and X-7/7 trial at the BEST OF ASCO 2023 held in Bangalore
  • Poster presentation at ISMPOCON 2024
  • Oral presentation at AMPOK 2024 in Cochin, Kerala
  • Oral presentation at BEST OF ASCO 2025 held in Bangalore
  • Assessment of chemotherapy dosing and regimen optimization in geriatric oncology patients diagnosed with solid organ malignancies, a retrospective observational study
  • A prospective study on low dose Nivolumab as induction with weekly Paclitaxel and Carboplatin in locally advanced head and neck cancers
  • Real world data on biomarker driven treatment of lung cancer with and without chemotherapy Ongoing research:
  • Correlation of TILs and Pathological complete CR in breast cancer patients who have received NACT
Registration and Membership:
  • Karnataka Medical council: 112053
  • API Membership
  • ISMPO Membership
  • ESMO Membership